THE ISSF HEARING PROCESS

The Shooter or his/her Member Federation must inform the ISSF if a Therapeutic Use Exemption (TUE) has been granted permitting the use of the substance detected in the positive test. If a TUE has been granted, this will eliminate the anti-doping rule violation for that substance.

REMEMBER: The ISSF does not grant TUE’s for beta blockers to any Shooter competing at the international level and the ISSF shall never recognize a national level TUE for beta blockers granted to an international level Shooter for any ISSF sanctioned event. An adverse analytical finding for a beta-blocker will usually result in a 2 year sanction and suspension.

If a TUE has not been obtained but the application process for a TUE is underway, provide all relevant details to the ISSF regarding why the TUE has not been obtained. The ISSF Anti-Doping Rules could allow for a retroactive approval of a TUE in the case of asthma medication, “medical emergencies” or “exceptional circumstances”.

Therapeutic Use Exemption Forms can be downloaded here: ISSF TUE Application Form.

When the ISSF is not the results management authority and does not conduct the hearing, in other words, when the adverse analytical finding derives from a national level test and a national level hearing panel renders a decision on a doping matter, or fails to render a decision on a doping matter, that decision is subject to a review by the ISSF Executive Committee in accordance with article 5.16 of the ISSF Anti-Doping Rules.

The ISSF  Executive Committee’s right to review a decision, or lack of a decision, that is clearly not in compliance with the Code is consistent with the requirement that the principles of the ISSF Anti-Doping Rules and the Code must be respected and properly implemented.